Currently, the expression of DNA repair genes such as the enzyme O-6-methylguanine-DNA methyltransferase (MGMT) and Excision Repair Cross-Complementation Group 1 (ERCC1) plays a potential role in colorectal cancer progression [3,4]. This evidence concerns the gene MGMT and colorectal cancer.